With the increasing use of AI, the working reality of managers and employees is changing. Decisions are increasingly being prepared or supported by AI.
Leadership is thus shifting from operational decision-making to organization, evaluation, and responsibility.
At the same time, two-thirds of decision-makers express concern that the use of AI could diminish the importance of key thinking skills such as problem solving, creativity, and critical thinking. Many companies see a need to set up targeted programs to strengthen human skills by 2030.
of decision-makers believe that by 2030, heavy reliance on AI will cause companies to lose key skills in problem solving, innovation, and entrepreneurial thinking – and thus lose their adaptability and competitive edge.
Fear of loss of competence due to AI
All employees will need to adapt to new roles and skill requirements. The use of AI makes targeted change management essential—particularly through continuous upskilling. At the same time, core capabilities such as problem-solving, innovation, and entrepreneurial thinking must not be neglected. Around 67 percent of respondents warn that growing dependence on AI could weaken exactly these skills, putting long-term adaptability and competitiveness at risk.
People before machines
The use of AI requires strategic consideration, as it fundamentally changes the roles of employees and managers. In the future, AI systems will increasingly take on analytical and operational tasks, making human skills such as creativity, empathy, and ethical judgment more important. Companies should specifically promote these skills in order to successfully shape change.
Decision-makers believe that by 2030, creativity, empathy, and ethical judgment will be the most valuable human skills, while analytical and operational tasks will be largely automated.
Decision-making authority remains with humans, who ultimately bear responsibility. This credo is at the heart of all our AI training courses.
Dr. Kerstin Borgards, Global Head of Strategy Realization and Process Improvements – Pharma Clinical Manufacturing Network, Roche
